The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

Investigators calculated annual OOP and total medication costs for five common neurological diseases. These included 186,144 ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 202 ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

I am an 81-year-old man in reasonably good health. When I had trouble falling asleep, I would take a swig of Zzzquil, which worked perfectly every time.

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

The recall covers more than 7,000 bottles of duloxtine, sold as Cymbalta, due to the presence of nitrosamines.

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...